X0202 4 2006-10-05 0 0000930184 VALEANT PHARMACEUTICALS INTERNATIONAL VRX 0001129787 VA PARTNERS LLC 435 PACIFIC AVENUE FOURTH FLOOR SAN FRANCISCO CA 94133 0 0 1 0 0001375350 VA Partners III, LLC 435 PACIFIC AVENUE, 4TH FLOOR SAN FRANCISCO CA 94133 0 0 1 0 0001351069 ValueAct Capital Management, L.P. 435 PACIFIC AVENUE, 4TH FLOOR SAN FRANCISCO CA 94133 0 0 1 0 0001351073 ValueAct Capital Management, LLC 435 PACIFIC AVENUE, 4TH FLOOR SAN FRANCISCO CA 94133 0 0 1 0 0001159187 UBBEN JEFFREY W 435 PACIFIC AVENUE, FOURTH FLOOR SAN FRANCISCO CA 94133 0 0 1 0 0000937541 KAMIN PETER H 265 FRANKLIN STREET, 16TH FLOOR BOSTON MA 02110 0 0 1 0 Common Stock, par value $.01 per share 2006-10-05 4 P 0 5600 20 A 1066500 I See Footnote Common Stock, par value $.01 per share 2006-10-06 4 P 0 50000 19.99 A 1116500 I See Footnote Common Stock, par value $.01 per share 2006-10-10 4 P 0 57600 19.82 A 1174100 I See Footnote Common Stock, par value $.01 per share 10871200 I See Footnote The reported stock is owned directly by ValueAct Capital Master Fund III, L.P. and may be deemed to be beneficially owned by (i) VA Partners III, LLC as General Partner of ValueAct Capital Master Fund III, L.P., (ii) ValueAct Capital Management, L.P. as the manager of ValueAct Capital Master Fund III, L.P. and (iii) ValueAct Capital Management, LLC as General Partner of ValueAct Capital Management, L.P. Jeffrey W. Ubben, Peter H. Kamin and George F. Hamel, Jr. are Managing Members of VA Partners III, LLC and ValueAct Capital Management, LLC. The reporting persons disclaim beneficial ownership of the reported stock except to the extent of their pecuniary interest therein. The reported stock is owned directly by ValueAct Capital Master Fund, L.P and may be deemed to be beneficially owned by (i) VA Partners, LLC as General Partner of ValueAct Capital Master Fund, L.P., (ii) ValueAct Capital Management, L.P. as the manager of of ValueAct Capital Master Fund, L.P. and (iii) ValueAct Capital Management, LLC as General Partner of ValueAct Capital Management, L.P. Jeffrey W. Ubben, Peter H. Kamin and George F. Hamel, Jr. are Managing Members of VA Partners, LLC and ValueAct Capital Management, LLC. The reporting persons disclaim beneficial ownership of the reported stock except to the extent of their pecuniary interest therein. Joint Filer Information: Name: ValueAct Capital Master Fund, L.P. Address: 435 Pacific Avenue, 4th Floor, San Francisco, CA 94133 Designated Filer: VA Partners, LLC Issuer and Ticker: Valeant Pharmaceuticals Intl (VRX) Date of Event Requiring Statement: Oct. 5, 2006 Name: ValueAct Capital Master Fund III, L.P. Address: 435 Pacific Avenue, 4th Floor, San Francisco, CA 94133 Designated Filer: VA Partners, LLC Issuer and Ticker: Valeant Pharmaceuticals Intl (VRX) Date of Event Requiring Statement: Oct. 5, 2006 Name: VA Partners III, LLC Address: 435 Pacific Avenue, 4th Floor, San Francisco, CA 94133 Designated Filer: VA Partners, LLC Issuer and Ticker: Valeant Pharmaceuticals Intl (VRX) Date of Event Requiring Statement: Oct. 5, 2006 Name: ValueAct Capital Management, L.P. Address: 435 Pacific Avenue, 4th Floor, San Francisco, CA 94133 Designated Filer: VA Partners, LLC Issuer and Ticker: Valeant Pharmaceuticals Intl (VRX) Date of Event Requiring Statement: Oct. 5, 2006 Name: ValueAct Capital Management, LLC Address: 435 Pacific Avenue, 4th Floor, San Francisco, CA 94133 Designated Filer: VA Partners, LLC Issuer and Ticker: Valeant Pharmaceuticals Intl (VRX) Date of Event Requiring Statement: Oct. 5, 2006 Name: Jeffrey W. Ubben Address: 435 Pacific Avenue, 4th Floor, San Francisco, CA 94133 Designated Filer: VA Partners, LLC Issuer and Ticker: Valeant Pharmaceuticals Intl (VRX) Date of Event Requiring Statement: Oct. 5, 2006 Name: George F. Hamel, Jr. Address: 435 Pacific Avenue, 4th Floor, San Francisco, CA 94133 Designated Filer: VA Partners, LLC Issuer and Ticker: Valeant Pharmaceuticals Intl (VRX) Date of Event Requiring Statement: Oct. 5, 2006 Name: Peter H. Kamin Address: 435 Pacific Avenue, 4th Floor, San Francisco, CA 94133 Designated Filer: VA Partners, LLC Issuer and Ticker: Valeant Pharmaceuticals Intl (VRX) Date of Event Requiring Statement: Oct. 5, 2006 VA PARTNERS, LLC, By:/s/ George F. Hamel Jr., Managing Member 2006-10-10 VALUEACT CAPITAL MASTER FUND, L.P., By: VA PARTNERS, LLC, its General Partner, By:/s/ George F. Hamel Jr., Managing Member 2006-10-10 VALUEACT CAPITAL MASTER FUND III, L.P., By: VA PARTNERS III, LLC, its General Partner, By:/s/ George F. Hamel Jr., Managing Member 2006-10-10 VA PARTNERS III, LLC, By:/s/ George F. Hamel Jr., Managing Member 2006-10-10 VALUEACT CAPITAL MANAGEMENT, L.P., By: VALUEACT CAPITAL MANAGEMENT, LLC, its General Partner, By:/s/ George F. Hamel Jr., Managing Member 2006-10-10 VALUEACT CAPITAL MANAGEMENT, LLC, By:/s/ George F. Hamel Jr., Managing Member 2006-10-10 /s/ Jeffrey W. Ubben 2006-10-10 /s/ George F. Hamel, Jr. 2006-10-10